Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospect...
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)
About this item
Full title
Author / Creator
Totzeck, Matthias , Aide, Nicolas , Bauersachs, Johann , Bucerius, Jan , Georgoulias, Panagiotis , Herrmann, Ken , Hyafil, Fabien , Kunikowska, Jolanta , Lubberink, Mark , Nappi, Carmela , Rassaf, Tienush , Saraste, Antti , Sciagra, Roberto , Slart, Riemer H. J. A. , Verberne, Hein and Rischpler, Christoph
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Cardiotoxicity may present as (pulmonary) hypertension, acute and chronic coronary syndromes, venous thromboembolism, cardiomyopathies/heart failure, arrhythmia, valvular heart disease, peripheral arterial disease, and myocarditis. Many of these disease entities can be diagnosed by established cardiovascular diagnostic pathways. Nuclear medicine, h...
Alternative Titles
Full title
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_uu_490245
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_490245
Other Identifiers
ISSN
1619-7070,1619-7089
E-ISSN
1619-7089
DOI
10.1007/s00259-022-05991-7
